Navigation Links
Survey Sampling International Names Chris DeAngelis to Head New SSI Health
Date:3/15/2011

SHELTON, Conn., March 15, 2011 /PRNewswire/ -- Survey Sampling International (SSI)—the leading global provider of online and offline sampling solutions—has appointed Chris DeAngelis to head its new SSI Health business, created to support the unique sampling requirements of health-related market research projects.  Bringing SSI's 34-year legacy of sampling science to health-focused industries, SSI Health provides access to all major healthcare audiences—patients, caregivers, physicians and allied health professionals, including nurses/nurse practitioners, pharmacists, chiropractors and dentists.  Its reach extends across a range of therapeutic categories, including metabolic syndrome, central nervous system and mental health disorders, respiratory ailments and lifestyle treatments.

"Recognizing the unique challenges healthcare researchers face, SSI has created a dedicated team, focused on creating and delivering sample for health-related projects," says Mr. DeAngelis.  "As the treatment decision process becomes more complex and therapies become more specific, health-focused researchers must meet two conflicting goals—achieving greater reach to more audiences while supporting more precise targeting of lower-incidence populations.  With the advent of SSI Dynamix™—our game-changing dynamic sampling platform—SSI is uniquely able to fulfill both key requirements.  

"By linking to multiple sources—including our global online panels, as well as social media, affiliate partnerships, online communities and more—SSI can access anyone who wants to share opinions and experiences, even those who would never join a panel.  Plus, because we dynamically profile in real time— using multiple sets of refinement questions—we can recruit very specific segments to meet even the tightest parameters."

In addition to its online access, SSI Health offers the full spectrum of offline modes, including landline phone, mobile/wireless and Address-Based Sampling.  It also provides mixed access solutions, combining multiple modes.  By offering a range of data collection approaches, SSI ensures healthcare researchers can reach any audiences they need—even populations with rare conditions, segments not well covered by the Internet and patients in cell-only households.    

Chris DeAngelis Brings 25 Year of Sampling Experience to His New Role

Mr. DeAngelis brings 25 years of sampling expertise to his new role.  He first joined SSI in 1986 as an Account Executive and quickly moved up the ranks, rising to Senior Account Executive in 1991, National Sales Manager in 1997 and Vice President, Sales, North America in 2003.  

Mr. DeAngelis is a member of the MRA, AAPOR, PMRG and PBIRG.  He holds a BA in Economics from Bates College and an MBA in Marketing from the University of Bridgeport.  He also spent a year studying Economics in the UK.          

"Chris acts as a true partner to his customers, supporting them in creating the most effective sampling and survey designs," says Mark Hardy, SSI's Managing Director, Americas.  "His extensive experience across multiple industries, including healthcare, coupled with his deep understanding of sampling science make him the ideal candidate to lead SSI Health.  Chris brings the knowledge, experience and passion for methodological excellence to deliver optimal sampling solutions for health-related projects."

About Survey Sampling International

Survey Sampling International (www.surveysampling.com) is the premier global provider of sampling solutions for survey research. SSI reaches respondents in 72 countries via Internet, telephone and mobile/wireless.  Value-add services include questionnaire design consultation, programming and hosting, and data processing.  SSI serves more than 2,000 clients, including 48 of the top 50 research organizations. Founded in 1977, SSI has 17 offices in 15 countries.


'/>"/>
SOURCE Survey Sampling International (SSI)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Global Physician Survey on Stents, Stent-Grafts and Vulnerable Plaque Treatment 2011
2. Thats Nice LLC Launches Nice Insight Marketing Intelligence for CRAMs With Its Pharma & Biotech Outsourcing Survey
3. Survey Finds Patients Oppose Prescription Mandate for OTC Medicines Containing Pseudoephedrine
4. Sixty Percent of Surveyed Type 2 Diabetes Patients in the U.S. Who Use Insulin Indicate They Would Request a Switch to a Less Expensive Biosimilar Insulin if Such an Agent Became Available
5. On Average, 55 Percent of Surveyed U.S. Asthma Patients Say They Are Likely to Request a Switch to a Drug With Efficacy Comparable to Their Current Medication but Which is Dosed Just Once a Day
6. Reportlinker Adds Healthcare Reform: 2010 Medical Device Industry Perceptions Survey
7. A Majority of Surveyed PCPs and Endocrinologists Indicate that they will Prescribe Contrave, Lorqess and Qnexa if these Therapies are Approved for Obesity
8. Activity Against Key Drug-Resistant Pathogens is the Most Important Attribute Influencing Surveyed Physicians Antibiotic Selection for Nosocomial Pneumonia in the U.S.
9. Survey Reveals Majority of Americans Hold onto Myths About What Causes Colds and How to Treat Them
10. New Survey Highlights Immediate Need for Anesthesia Information Management Systems
11. For the Treatment of Rheumatoid Arthritis, Surveyed European Rheumatologists Expect Well-Established TNF-Alpha Inhibitors to Lose Considerable Patient Share to Newer Agents in This Drug Class
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017 Under ... Chinese pharmaceutical packaging market size increased year by ... From 2017 to 2021, the market size will ... is expected to outnumber RMB140 billion in 2021, ... the rapid development of biological agents and supporting ...
(Date:3/22/2017)... Pennsylvania , 22. März 2017 /PRNewswire/ ... unabhängige und weltweit tätige Anbieter von Produkten ... heute den Erwerb von EPL Archives Inc. ... Stoffe, der Kunden im kompletten Zyklus regulierter ... Verwahrung von Proben, Speicherung von Dokumenten und ...
(Date:3/22/2017)... 22, 2017  Applied BioMath ( www.appliedbiomath.com ), ... research and development, today announced the latest line-up ... 2017 is a day full of presentations, posters, ... (QSP) community. The focus is to learn about ... accelerating drug research and development. The ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... Ogden Clinic, the largest ... centric payment system, to expand its focus on patient care by providing an ... , “At Ogden Clinic, we are working to become a different type ...
(Date:3/23/2017)... ... March 23, 2017 , ... Vortex Biosciences, provider of circulating ... in circulating tumor cells using microfluidic western blotting” in Nature Communications on March ... technology to capture CTCs and a microfluidic single-CTC resolution Western blot from ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... providing insurance assistance, financial planning, and related services to residents of the region, ... promote awareness of threatened species and wild lands. , Endangered Species International is ...
(Date:3/22/2017)... ... March 22, 2017 , ... Soriant recognizes that ... bypasses that. Healthcare facilities across the country are always forced to focus ... and hospitals, across the country, an efficient and quick way to estimate savings ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... that its digital marketing solutions have enabled Children’s Hospital of The King’s Daughters ... , Recognizing the value of a digital marketing approach, the 206-bed pediatric ...
Breaking Medicine News(10 mins):